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Mutations in the gene encoding fibrillin are the causeof Marfan syndrome, an autosomal dominant dis-order with skeletal, ocular, and cardiovascularcomplications. The leading cause of premature
death in patients with Marfan syndrome is progressive dilatation of
the aortic root and ascending aorta, resulting in aortic regurgitation
and acute aortic dissection.1,2
Clinical Summary
A 24-year-old woman with Marfan syndrome was admitted to our
department because a routine computed tomographic (CT) scan
revealed a Crawford type II thoracoabdominal aortic aneurysm
with a maximum diameter of 5 cm. Other manifestations of Marfan
syndrome exhibited by the patient included hyperextensible joints
and bilateral inguinal hernia.
A replacement of the thoracoabdominal aorta with deep hypo-
thermia and circulatory arrest was subsequently performed on
February 2, 1992. Visceral vessels were reimplanted by using the
Carrel patch technique. The postoperative course was complicated
through a reperfusion edema of the right lung requiring an upper
lobe lobectomy on postoperative day 10 and a compartment syn-
drome at the cannulation leg for cardiopulmonary bypass. Finally,
the patient recovered and could be discharged after 32 days.
Microscopic histologic examination of the aortic wall revealed
cystic medial necrosis.
Regular follow-up every 6 months showed a regularly perfused
graft with a closed entry tear. The other aortic regions were
without further enlargement.
Three years later, in 1995, the patient underwent emergency
replacement of the ascending thoracic aorta with a 32-mm Vas-
cutek prosthesis (Sulzer Vascutek vascular prosthesis; Sulzer Med-
ica Ltd, Renfrewshire, Scotland) and aortic valve with a Carbo-
medics 25-mm mechanical prosthesis (Sulzer Medica) as a result
of acute aortic dissection type A.
After an uneventful postoperative course, the patient was dis-
charged on postoperative day 11.
Follow-up CT scan in March 1997 showed an aneurysm of the
brachiocephalic trunk extending into the right subclavian artery,
requiring replacement of the 2 arteries
In April 1999, a new aneurysm in the area of the Carrel patch
visceral arteries was detected. Because the patient refused to
undergo another operation with deep hypothermia and circulatory
arrest, we decided to implant a stent graft at the site of the new
aneurysm (Figure 1, A). As preparation before stent graft implan-
tation, bypasses from the visceral arteries to the thoracoabdominal
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Figure 1. A, CT scan showing the new aneurysm at the implan-
tation site of the renal arteries. B, CT scan after successful
exclusion of the aneurysm with 2 Gore Excluder stent grafts
deployed into the Vascutek prosthesis at the site of the new
aneurysm at the origin of the visceral arteries.
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Figure 2. A, Angiogram before stent graft and before interposition of Dacron grafts from the visceral arteries to the
thoracoabdominal prosthesis. B, Angiogram after stent graft deployment into the thoracoabdominal aortic pros-
thesis and connection of the renal arteries, the splenic artery, the celiac trunk, and the superior mesenteric artery
with Dacron grafts into the prosthesis.
Figure 3. Three-dimensional magnetic resonance angiography from the last follow-up in July 2002 (4 years after
placement). The stent graft is regularly perfused, and no migration has occurred since the last follow-up
examination. No visible endoleak could be detected.
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prosthesis were constructed because the origins of the visceral
arteries will be occluded by the stent graft. Therefore a 32-mm
infrarenal tube graft was implanted to serve as a distal landing
zone for the stent graft (Sulzer Medica). Moreover, two 6-mm
Dacron prostheses (Uni Graft KDV; B. Braun GmbH, Melsungen,
Germany) were implanted as bypass conduits to the renal arteries.
Subsequently, 8-mm Dacron grafts were interpositioned to the
splenic artery, the celiac trunk, and the superior mesenteric artery
(Figure 2, B).
In a second-stage procedure in June 1999, the whole thoraco-
abdominal aorta was stented with 2 Gore Excluder stents (40 mm
in diameter and 20 cm in length; W.L. Gore & Associates, Inc,
Flagstaff, Ariz) through the right femoral artery. (Figure 2, A, and
Figure 1, B)
Since then, no more aneurysms occurred thus far. A close
follow-up with CT scans and angiography of the entire aorta and
its branches is done every 6 months to attempt to recognize any
changes (Figure 3).
Discussion
Several studies had been conducted to determine survival and
event-free survival in patients with Marfan syndrome.3,4 They
showed that at least 34% of patients with Marfan syndrome will
have serious cardiovascular complications requiring major cardiac
surgery in the first 10 years after diagnosis. The predominant
cardiovascular manifestation of the Marfan syndrome affect the
aortic root and ascending aorta counting for 82% overall mortality
in these patients. Recent reports emphasized the importance of
prophylactic replacement of the aortic root in these patients, which
improves 10-year survival to 97% compared with 34% in patients
who did not undergo surgical intervention.3 Recurrent evaluation
of the entire aorta in short intervals remains the mainstay of
follow-up investigations in patients with Marfan syndrome. How-
ever, in a few patients, such as the one presented here, aneurysms
also develop in aortic branches.3,4 The possibility of aneurysms
developing in aortic branches, as in the subclavian or carotid
arteries in patients with Marfan syndrome, strongly suggests the
importance of close observation not only of the aorta but also of
the visceral and supra-aortic branches.
Endovascular stent graft implantation emerged as an effective
and valuable treatment alternative for patients with aortic diseases
otherwise not amenable to conventional repair for a variety of
reasons,5 which was the driving force for us to administer this
treatment modality to our patient.
This case implies the stringency of regular follow-up exami-
nations in patients with Marfan syndrome, even when replacement
of the entire thoracic and abdominal aorta has already been per-
formed.
The development of aneurysms of the aortic branches is a rare
manifestation in Marfan syndrome, but when it occurs, it has
significant effect on quality of life and long-term survival in these
patients.
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